DragonWave, Inc.(USA)  

(Public, NASDAQ:DRWI)   Watch this stock  
Find more results for DRWI
0.760
-0.010 (-1.30%)
After Hours: 0.760 0.000 (0.00%)
Jun 23, 4:00PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.75 - 0.78
52 week 0.64 - 6.83
Open 0.75
Vol / Avg. 161,632.00/929,439.00
Mkt cap 6.30M
P/E     -
Div/yield     -
EPS -3.49
Shares 8.50M
Beta 1.31
Inst. own     -

Key stats and ratios

Q1 (Feb '17) 2017
Net profit margin -47.75% -35.74%
Operating margin -67.93% -37.52%
EBITD margin - -32.60%
Return on average assets -34.88% -33.02%
Return on average equity - -
Employees 278 -
CDP Score - -

Address

411 Legget Dr Suite 600
KANATA, ON K2K 3C9
Canada
+1-613-5999991 (Phone)
+1-613-5994265 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

DragonWave Inc (DragonWave) is a provider of packet microwave solutions for Internet protocol (IP) networks. The Company operates through broadband wireless backhaul equipment segment. The principal application of DragonWave's products is mobile network backhaul. Additional applications include leased line replacement, last mile fiber extension and enterprise networks. The Company's product lines include Harmony, Horizon, Avenue and NetViewer. The Harmony product line is a multi-service wireless platform enabling time division multiplexing (TDM) and packet-based services across wireless or wireline infrastructure. The Company's Horizon product family is an Ethernet microwave portfolio and consists of Horizon Compact+ and Horizon Quantum. Its NetViewer is a multi-service, multi-product network management platform. The NetViewer enables provisioning, management, monitoring and configuration across the line of products in a single graphical user interface (GUI)-based system.

Officers and directors

Claude Carman Haw Independent Chairman of the Board
Bio & Compensation  - Reuters
Peter Allen President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Patrick Belanger Houston Interim Chief Financial Officer
Bio & Compensation  - Reuters
Barry Dahan Executive Vice President - Global Sales
Bio & Compensation  - Reuters
David Farrar Vice President - Operations
Bio & Compensation  - Reuters
Erik Boch Vice President - Engineering, Chief Technology Officer
Bio & Compensation  - Reuters
Greg Friesen Vice President - Product Management
Bio & Compensation  - Reuters
Tom McLellan Vice President - Services
Bio & Compensation  - Reuters
Cesar Cesaratto Independent Director
Age: 68
Bio & Compensation  - Reuters
Lori O'Neill Independent Director
Bio & Compensation  - Reuters